pulepuboboding @pulepuboboding

Doctor Sigapore Joined December 2016

Tweets

7K
Followers

934
Following

2K
Likes

4K

pulepuboboding @pulepuboboding

2 years ago

A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. qxmd.com/r/37210048

0 1 2 403 0

pulepuboboding @pulepuboboding

2 years ago

The Accelerators Podcast accelerators.buzzsprout.com

0 1 3 330 0

Bartomeu Massuti @bmassutis

3 years ago

Resistance to immunotherapy: a new challenge and a new frontier? #WCLC22 ⁦@OncoAlert⁩

0 8 29 0 2

Download Image

pulepuboboding @pulepuboboding

4 years ago

Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. qxmd.com/r/34379442

0 0 4 0 0

pulepuboboding @pulepuboboding

4 years ago

Hippocampal Avoidance Prophylactic Cranial Irradiation: A New Standard of Care? qxmd.com/r/34379456

0 0 3 0 1

pulepuboboding @pulepuboboding

4 years ago

Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer. qxmd.com/r/34428095

0 0 2 0 0

pulepuboboding @pulepuboboding

4 years ago

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial. qxmd.com/r/34541864

0 0 2 0 0

pulepuboboding @pulepuboboding

4 years ago

Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot? qxmd.com/r/34559553

0 0 1 0 0

pulepuboboding @pulepuboboding

4 years ago

Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. qxmd.com/r/34623894

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study. qxmd.com/r/34662180

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. qxmd.com/r/34724392

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Inoperable Early-Stage Non-Small-Cell Lung Cancer: Stereotactic Ablative Radiotherapy and Rationale for Systemic Therapy. qxmd.com/r/34985921

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options. qxmd.com/r/34985925

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer. qxmd.com/r/34985927

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Systemic and Radiation Therapy Approaches for Locally Advanced Non-Small-Cell Lung Cancer. qxmd.com/r/34985931

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer. qxmd.com/r/34985935

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent. qxmd.com/r/34985936

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. qxmd.com/r/34985992

0 0 0 0 0

pulepuboboding @pulepuboboding

4 years ago

Survival Outcomes of Patients With Borderline Resectable and Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Short-Course Chemoradiotherapy With Capecitabine-Based vs. Gemcitabine-Based Concurrent Chemotherapy. qxmd.com/r/34701938